Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kronos Bio, Inc. | Chief Financial Officer | Common Stock | 164K | $173K | $1.05 | Jun 3, 2024 | Direct |
Kronos Bio, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 246K | Jun 3, 2024 | Direct | ||
Senti Biosciences, Inc. | Chief Financial Officer, Head of Corporate Development | Stock Option (Right to Buy) | 152K | Feb 1, 2024 | Direct | ||
Senti Biosciences, Inc. | Chief Financial Officer, Head of Corporate Development | Common Stock | 131K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KRON | Kronos Bio, Inc. | Jun 3, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Chief Financial Officer |
KRON | Kronos Bio, Inc. | Jun 3, 2024 | 0 | $0 | 3 | Jun 4, 2024 | Chief Financial Officer |
SNTI | Senti Biosciences, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 2, 2024 | Chief Financial Officer, Head of Corporate Development |
SNTI | Senti Biosciences, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer |
SNTI | Senti Biosciences, Inc. | Oct 3, 2022 | 2 | $0 | 4 | Oct 4, 2022 | Chief Financial Officer |
SNTI | Senti Biosciences, Inc.\ | Jun 8, 2022 | 0 | $0 | 3 | Jun 15, 2022 | Chief Financial Officer |